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Abstract
Knowledge of x-ray attenuation is essential for developing and evaluating x-ray imaging 
technologies. In mammography, measurement of breast density, dose estimation, and 
differentiation between cysts and solid tumours are example applications requiring accurate 
data on tissue attenuation. Published attenuation data are, however, sparse and cover a 
relatively wide range. To supplement available data we have previously measured the 
attenuation of cyst fluid and solid lesions using photon-counting spectral mammography. The 
present study aims to measure the attenuation of normal adipose and glandular tissue, and to 
measure the effect of formalin fixation, a major uncertainty in published data. A total of 27 
tumour specimens, 7 fibro-glandular tissue specimens, and 15 adipose tissue specimens were 
included. Spectral (energy-resolved) images of the samples were acquired and the image signal 
was mapped to equivalent thicknesses of two known reference materials, from which x-ray 
attenuation as a function of energy can be derived. The spread in attenuation between samples 
was relatively large, partly because of natural variation. The variation of malignant and 
glandular tissue was similar, whereas that of adipose tissue was lower. Formalin fixation 
slightly altered the attenuation of malignant and glandular tissue, whereas the attenuation of 
adipose tissue was not significantly affected. The difference in attenuation between fresh 
tumour tissue and cyst fluid was smaller than has previously been measured for fixed tissue, 
but the difference was still significant and discrimination of these two tissue types is still 
possible. The difference between glandular and malignant tissue was close-to significant; it is 
reasonable to expect a significant difference with a larger set of samples. We believe that our 
studies have contributed to lower the overall uncertainty of breast tissue attenuation in the 
literature due to the relatively large sample sets, the novel measurement method, and by 
clarifying the difference between fresh and fixed tissue.
1. Introduction
Basic knowledge of the x-ray attenuation of tissue is essential for the development of new x-ray imaging 
technologies as well as for the study of existing technologies. Unenhanced spectral imaging, for example, 
is an emerging x-ray imaging technology that measures tissue properties, without injection of a contrast 
agent, using differences in attenuation as a function of energy (Fredenberg 2018).
In the field of mammography, efforts have been made to employ unenhanced spectral imaging to 
improve tumour visibility, but this exercise has so far proven difficult to realize because of the small 
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difference in linear attenuation between malignant tissue and normal glandular tissue (Johns and Yaffe 
1987). It may, however, be less complicated to differentiate between cyst fluid and solid tissue. Round 
lesions are common, and it can be difficult to distinguish between benign cysts and potentially malignant 
solid lesions using conventional x-ray imaging, particularly when the margin is partly obscured. Currently, 
recall rates from screening mammography are approximately 5% in Northern Europe and much higher in 
the United States (Smith-Bindman et al 2003), which is not only costly for the screening programme 
(Guerriero et al 2011), but also stressful for patients (Brett and Austoker 2001). Spectral imaging could 
potentially characterize a finding as cystic or solid in the screening image (Erhard et al 2016, Fredenberg et 
al 2013, 2016), thereby lowering the number of recalls and addressing the relatively low specificity of x-
ray mammography screening.
Another application of unenhanced spectral imaging is measurement of the volumetric breast density 
(Ding and Molloi 2012, Johansson et al 2017), i.e., the fraction of fibro-glandular tissue in the breast. 
Accurate measures of breast density have the potential to improve risk assessments (Tice et al 2008), which 
in turn facilitates the transformation from population-based to stratified screening in order to increase 
sensitivity and minimize the cost of screening (Schousboe et al 2011). Breast density also provides 
important input to dose calculations (Dance and Sechopoulos 2016), and may be employed as a biomarker 
in treatment monitoring (Li et al 2013).
Accurate tissue attenuation data is crucial to the development of spectral x-ray techniques, such as 
lesion characterization and breast-density measurement. Accordingly, we have developed a method to 
measure the energy-dependent x-ray attenuation of tissue samples, which uses spectral imaging to map 
tissue attenuation to equivalent thicknesses of two reference materials. The method has previously been 
applied to measure the attenuation of cyst fluid and formalin-fixed solid breast lesion specimens (Fredenberg 
et al 2013, 2016). These studies, which showed a significant separation between cyst-fluid and solid-tissue 
attenuation, marked the first two steps in our efforts to evaluate the feasibility of using unenhanced spectral 
imaging for lesion characterization and laid the groundwork for a clinical pilot study (Erhard et al 2016).
Our measurement of cyst-fluid attenuation was the first of its kind, and the study on solid lesions 
more than doubled the aggregated number of samples in the literature. Nevertheless, these studies focused 
on lesion attenuation and no samples of normal tissue were included, despite the fact that adipose and 
glandular tissues make up the bulk of the breast and their attenuation properties are therefore of the utmost 
importance. Preliminary investigations have shown that data available in the literature on normal tissue 
attenuation exhibit a relatively large spread (Fredenberg et al 2015). The same situation exists for tumour 
attenuation, and the spread may be attributed to the limited number of samples in each study, which limits 
the accuracy of the estimated expectation values, but also to the different measurement setups employed 
(Fredenberg et al 2016). We therefore see a need to measure the attenuation of normal tissue within the 
same framework as we have used on lesions in order to make meaningful comparisons possible. We also 
see a need to contribute more samples to the available literature in order to reduce the overall error of the 
mean.
Further, our previous study on solid tissue was conducted on formalin-fixed specimens, which 
constitutes a considerable uncertainty. To our knowledge, not more than a single study has investigated the 
effect of fixation on breast-tissue attenuation; Chen et al (2010) did not find any significant difference 
between fresh and fixed adipose tissue, but the authors did report significant effects on glandular and tumour 
tissue. Fredenberg et al (2016) raised worries that fixation therefore might impact the separation of solid 
lesions from cysts, but the number of samples in Chen et al (2010) was relatively small (six) and the 
measurements were conducted in a relatively narrow energy range (17-23 keV). We therefore see a need to 
measure and compare the attenuation of a larger number of fresh and fixed specimens under conditions that 
are similar to the clinical environment.
Published data that are useful to determine the energy-dependent x-ray attenuation can be broadly 
categorized into two groups: 1) measurements of the elemental composition, which, in combination with 
elemental attenuation coefficients, can be used to calculate the linear attenuation according to the mixture 
rule, and 2) direct measurements of the linear attenuation coefficients. The perhaps most widely spread 
study on elemental composition was published by Hammerstein et al (1979) in order to make dose estimates 
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and included samples of normal adipose and glandular tissue. Woodard and White (1986) added 
measurements from a few additional specimens of glandular tissue to the Hammerstein data, and these 
results were later cited in ICRU report 46 (ICRU 1992). Poletti et al (2002) measured the elemental 
composition of normal breast tissue samples as an intermediate step to determine angular scattering 
distributions. Relatively large differences compared to the Hammerstein data were noted for adipose tissue, 
whereas the measurements on glandular tissue agreed better. Pioneering direct attenuation measurements 
were presented by Johns and Yaffe (1987), who measured the linear attenuation coefficient of normal and 
cancerous tissue using a broad x-ray spectrum and a spectroscopy detector. Later, Carroll et al (1994) and 
Chen et al (2010) instead used monochromatic synchrotron radiation. Tomal et al (2010) used an x-ray tube 
and a silicon monochromator to measure the linear attenuation of breast tissue.
The purpose of the current study is to fill the above mentioned gaps in previous studies on breast-
tissue attenuation and is therefore twofold: 1) to measure the x-ray attenuation of normal breast tissue, and 
2) to measure the effect of formalin fixation on x-ray attenuation. Our immediate need for such data is to 
pursue the development of spectral imaging applications, but data on tissue attenuation may also have 
general value for the scientific community as the sources of such data are sparse.
2. Materials and Methods
2.1. Background of spectral imaging
The measurement procedure has been generally described in our previous publications (Fredenberg et al 
2013, 2016), but is summarized here for clarity, and any differences are provided.
All measurements were conducted on a Philips MicroDose SI, which is a photon-counting spectral 
mammography system in a scanning multi-slit geometry. The tungsten-target x-ray tube is filtered with 
aluminium, and images were acquired at 32 kV acceleration voltage and an exposure level of 40 mAs. The 
scanning multi-slit geometry of the MicroDose system rejects virtually all scattered radiation (Åslund et al 
2006). A low-energy threshold in the electronics rejects virtually all electronic noise. An additional high-
energy threshold was set close to 20 keV to sort detected photons according to energy into two bins with 
approximately equal size. The energy resolution at this energy level is approximately 5 keV (Fredenberg et 
al 2010). The images were sub-sampled from 50 µm to 100 µm pixel size to facilitate the additional image 
processing carried out within the study.
X-ray attenuation at mammographic x-ray energies is approximately made up of only two 
independent interaction effects, namely photoelectric absorption and scattering processes (Alvarez and 
Macovski 1976, Lehmann et al 1981, Johns and Yaffe 1987, Fredenberg 2018). Accordingly, a linear 
combination of any two materials of different and low atomic number can approximately simulate the 
energy-dependent attenuation of a third material of a given thickness,
𝑡sample𝜇sample(𝐸) = 𝑡1𝜇1(𝐸) + 𝑡2𝜇2(𝐸). (1)
We call these materials reference materials, and if this relationship is assumed to hold exactly, then the 
associated normalized reference thicknesses  are unique descriptors of the energy dependent [𝑡1,𝑡2]/𝑡sample
sample attenuation ( ) given the known attenuations of the reference materials (  and ). In other 𝜇sample 𝜇1 𝜇2
words, the detected signal in an x-ray detector would be identical for a tissue sample and for the equivalent 
combination of reference materials, regardless of incident energy spectrum or detector response.
Our method to measure the energy-dependent x-ray attenuation of tissue samples builds on Eq. (1) 
using aluminium (Al) and polymethyl methacrylate (PMMA) as the two reference materials. In common 
with previous studies (Lehmann et al 1981, Johns and Yaffe 1987), it is useful to also express the equivalent 
Al and PMMA thicknesses in terms of the corresponding Al-PMMA vector with magnitude and angle given 
by
𝑟 = 𝑡2Al + 𝑡2PMMA          and        𝜃 = tan ―1 ( 𝑡Al𝑡PMMA). (2)
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The magnitude  is directly proportional to the thickness and the density (specific weight) of the sample, 𝑟
whereas the angle  is related to the attenuation energy dependence and the (effective) atomic number of 𝜃
the material, and is independent of sample thickness.
2.2. Spectral attenuation measurements
In total, 37 tissue samples of solid malignant breast lesions and 22 samples containing fibro-glandular and 
/ or adipose breast tissue were considered for the study. Ethical approval was obtained to use samples from 
women from whom generic consent had been obtained prior to surgery. Immediately post-surgery the tissue 
was sliced, the fresh tissue slices were promptly obtained from pathology, specimen images were acquired 
with the spectral mammography system, and the samples were returned without delay to pathology for 
formalin fixation. The same samples were again obtained from pathology post fixation to acquire a second 
set of spectral specimen images. The imaging and measurement procedure was carried out by an experienced 
radiographer (PW).
A provisional assessment of sample eligibility was conducted by visual inspection of the tissue. For 
the lesion samples it was required that at least one slice had the solid breast lesion clearly visible on both 
surfaces in order to avoid interference by other tissue types. For the normal tissue it was required that one 
of the slices contained homogeneous tissue through the entire slice for a reasonably large connected area. 
Due to the logistical constraints of obtaining tissue from, and returning it to, the pathology laboratory cut 
up room without disruption or delaying processing, final sample eligibility could only be verified after 
imaging had been performed.
Samples were placed in a hollow PMMA cylinder and were gently compressed and flattened by 
twisting the threaded lid. The sample thickness ( ) was calculated as the mean of a measurement with 𝑡sample
a protractor on the lid and a calliper measurement. Figure 1 shows photographs and x-ray images of sample 
holder and specimens. Regions-of-interest (ROIs) corresponding to homogeneous areas of adipose, fibro-
glandular, or malignant tissue were selected in each image. For tumour samples, one ROI was manually 
selected to cover part of the lesion and was automatically divided into four equal-sized sub ROIs in order to 
estimate inhomogeneities within the sample. For adipose and glandular tissue, homogeneous areas were in 
general scattered over the sample and four sub ROIs of varying size were instead manually selected at 
various locations over the sample. ROI selection was done by a medical physicist (EF) and confirmed or 
adjusted by an experienced radiologist (MGW). Care was taken to avoid microcalcifications in the ROIs. 
Each sample was oriented similarly for imaging of fresh and fixed tissue, and ROIs were placed at similar 
locations for the fresh and fixed tissue.
An Al and PMMA step wedge was positioned adjacent to the sample to provide a reference grid of 
thickness / material combinations. ROIs were automatically selected on each step of the step wedge by 
projecting the sample ROI in the scanning direction (Figure 1). The range of the step wedge was adapted to 
the sample thickness by placing thin PMMA plates and Al sheets (step-wedge plates) on top of the step 
wedge. Preliminary investigations showed that adipose tissue exhibits negative Al thicknesses in the Al-
PMMA space. To compensate for the negative thicknesses, adipose samples were imaged with an 
appropriate number of thin Al sheets (sample plates) above the sample. The thicknesses of PMMA and Al 
in the reference grid were calculated as the differences between the total thicknesses at the step-wedge ROIs 
(the sum of step-wedge plates, step wedge, and mounting plates) and the total thicknesses at the sample ROI 
(the sum of all sample holder components, sample plates, and mounting plates). The increased traversed 
thickness at oblique incidence was taken into account for all calculations.
X-ray attenuation was measured by mapping the high- and low energy counts obtained from the 
sample ROI against the reference grid obtained from the step-wedge ROIs. Linear Delaunay triangulation 
in the log domain was used for interpolation in the reference grid. In a limited number of cases, the range 
of the step wedge was misplaced and extrapolation by a second-degree surface in the log domain was 
employed outside the reference grid. Four images with identical ROI selection were acquired of each 
sample, but because Fredenberg et al (2016) concluded that the variation between subsequent images is 
minimal, the four readings were averaged without further analysis in the current study.
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Figure 1: X-ray images and photographs of the sample holder and step wedge. The left column shows fresh samples and the 
right column shows the corresponding fixed samples. Sample ROIs are indicated in green and step-wedge ROIs in red. The 
fresh-tissue images cover a larger part of the setup in order to give an overview of the arrangement. Top: A grade 2 invasive 
ductal carcinoma. The four sub-ROIs, which were found by automatically splitting the selected ROI, are seen as a gridded ROI. 
Bottom: A sample of normal adipose tissue. The four sub-ROIs were manually spread over the sample.
2.3. Measurement errors and variabilities
For tumour tissue samples, the variation between the sub ROIs (referred to as the intra-image variability, 
) can be assumed to be caused by quantum noise ( ), random measurement errors from position-𝜎intra I 𝜎quant I
dependent thickness variations of the measurement setup and the sample ( ), and intra-sample tissue 𝜎th I
variations ( ):𝜎intra S
σ2intra I =  𝜎2intra S + 𝜎2th I + 𝜎2quant I, (3)
where  was estimated by error propagation through the interpolation process, assuming knowledge 𝜎quant I
of the photon counts per pixel and a Poisson distribution. Compared to Fredenberg et al (2016),  was 𝜎quant I
a factor of two lower because the four readings of each sample were averaged in the present study.
The maximum error caused by linear interpolation of the slightly non-linear reference grid was 
estimated as the maximum deviation between the measured grid and a linear function extending from the 
periphery of the grid, divided over the edges of the grid. The expected variability caused by this error was 
estimated as the standard deviation of the rectangular distribution ranging from zero to the maximum error. 
Preliminary investigations showed that this variability on average amounted to less than 5 % of the quantum 
noise and the variability contribution from interpolation error was therefore ignored.
Fredenberg et al (2016) concluded that, for tumour tissue, inhomogeneity within an ROI was not a 
complete measure of sample inhomogeneity because the sub ROIs were located next to each other and 
covered only a portion of the lesion. In fact, no significant difference was found between  and  𝜎intra I 𝜎quant I
(i.e.,  for small ROIs). It is, however, likely that  and  do not represent normally 𝜎2intra S + 𝜎2th I ≈ 0 𝜎intra S 𝜎th I
distributed stationary random processes; low spatial-frequencies typically dominate in the thickness 
variation of PMMA, Al, and sample, and the same is generally true for breast tissue contrast (Cederström 
and Fredenberg 2014), which means that  and  can be expected to increase with distance between 𝜎th I 𝜎intra S
the sub ROIs. Hence, for the measurements on adipose / glandular tissue, these variabilities may contribute 
more to  because in that case the four sub ROIs were spread out over the sample, as opposed to tumour 𝜎intra I
tissue for which sub ROIs were located next to each other. Therefore, to estimate  for the measurements 𝜎th I
on adipose and glandular tissue, the thickness variations across the full area of the PMMA and Al 
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components were measured, and a sample thickness variation equal to the uncertainty of the sample 
thickness measurement was assumed. These variations were propagated through the interpolation process.
To estimate the expectation value for each sample of tumour tissue or normal adipose / glandular 
tissue, data from all sub ROIs were averaged. The spread between these values is referred to as the total 
variability:
𝜎2tot = 𝜎2inter S + 𝜎2th S + 14 × σ2intra I, (4)
where  is natural tissue variation between samples and  is the error caused by the per-sample 𝜎inter S 𝜎th S
thickness measurement. For tumour tissue,  also includes thickness variations of the PMMA and Al 𝜎th S
components as these are not captured by  without spacing between the sub ROIs. It is assumed that intra-𝜎th I
sample tissue variations ( ) are reduced by averaging the individual ROI measurements. Accordingly, 𝜎intra I
we define  to simplify notation in the following.𝜎quant S ≡ 1 2 × 𝜎quant I
The aggregated variability measures (  and ) were estimated as the standard deviation of 𝜎intra I 𝜎tot
measured data. As the number of samples were limited, we investigated the possibility to average the 
variabilities of fresh and fixed tissue in order to improve statistical power. We do not expect that the fixation 
process would affect variability, but the differences in total variability between fresh and fixed tissue were 
in any case tested for significance prior to averaging. As described above, quantum noise (  and 𝜎quant I
) was estimated on a per-measurement basis from the detected number of counts, and variabilities 𝜎quant S
caused by thickness variations (  and ) were estimated based on expected thickness errors for an 𝜎th I 𝜎th S
average sample or ROI. For more information about the procedures in estimating  and  we refer to 𝜎quant 𝜎th
our previous study (Fredenberg et al 2016).
Natural variation of tissue (  and ) was not estimated directly, but could to some extent 𝜎intra S 𝜎inter S
be inferred from Eq. (3) and Eq. (4). With , , and likely also  representing non-stationary, 𝜎intra S 𝜎th I 𝜎inter S
non-Gaussian processes, the validity of Eq. (3) and Eq. (4) is, however, limited; an additional assumption 
on equal ROI size and position is necessary. In fact, it is possible that the intra-sample ( ) and inter-𝜎intra S
sample ( ) variabilities are both caused by the same type of natural variation and that  𝜎inter S 𝜎intra S→𝜎inter S
as ROI size . A more thorough analysis of these variabilities is, however, not within the scope of the  →∞
current study. All variabilities and random measurement errors discussed above are summarized in Table 1.
Table 1: Summary of variabilities and random measurement errors discussed in Sec. 2.3.
Intra-image (ROI-to-ROI) variabilities Inter-sample (sample-to-sample) variabilities
𝜎intra I intra-image variability, total variation between 
ROIs
𝜎tot total variability, variation between samples
𝜎quant I quantum noise between ROIs 𝜎quant S quantum noise between samples
𝜎th I thickness variations between ROIs, caused by 
unevenness in measurement setup and sample
𝜎th S per-sample variations in the thickness 
measurement and in the measurement setup
𝜎intra S intra-sample tissue variations 𝜎inter S natural tissue variation between samples
In addition to the random measurement errors related to measurement precision ( , , ), 𝜎th I 𝜎th S 𝜎quant
we can expect systematic errors, related to measurement accuracy, caused by uncertainties in thickness and 
density that are constant for all measurements. We have estimated these systematic errors by propagation 
of thickness and density uncertainties according to Fredenberg et al (2016).
3. Results
Of the original 37 samples of solid malignant tissue, 10 samples were excluded from the study: 1 case was 
a DCIS with no mass lesion discernible on the images, 2 cases were benign fibroadenoma, and 7 cases were 
excluded for technical reasons, mainly because it was detected that tumour was not histologically present at 
both cut surfaces despite initial appearances of the fixed specimen block. Of the remaining 27 biopsy proven 
solid tissue specimens, 19 were invasive ductal carcinoma (3 grade I, 10 grade II, 6 grade III), 7 were lobular 
carcinoma (6 grade II, 1 grade III), and 1 was a grade I mucinous carcinoma. Of the original 22 samples of 
normal breast tissue, 4 samples were excluded from the study for technical reasons, mainly because no 
homogeneous area of either adipose or fibro-glandular tissue could be found within the sample. Of the 
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remaining 18 samples, 15 were used for measurements on adipose tissue and 7 were used for measurements 
on fibro-glandular tissue. The relatively large number of exclusions is due to the fact that final sample 
eligibility could only be verified after imaging had been performed, as discussed in Sec. 2.2.
The mean sample thicknesses, including fresh and fixed samples, were 6.8 mm (malignant tissue), 
6.0 mm (glandular tissue), and 6.2 mm (adipose tissue). The mean total ROI sizes (sum of four sub ROIs), 
including fresh and fixed samples, were 89 mm2 (malignant tissue), 486 mm2 (glandular tissue), and 227 
mm2 (adipose tissue). The substantially larger ROIs for adipose and glandular tissue were possible because 
of several large homogeneous areas in the samples over which the four sub ROIs could be spread, as opposed 
to the lesion samples where the malignant tissue was typically at a single confined location.
The systematic error caused by uncertainties in thickness and density of the measurement setup was 
estimated (c.f. Sec. 2.3) as 1-2 % and 1 % for an average sample in the Al- and PMMA-equivalent 
thicknesses, respectively. The variability caused by variations in thickness over the measurement area and 
random errors in the sample thickness measurements (  and ) was estimated for an average sample 𝜎th S 𝜎th I
to constitute 1-2 % and 0.5-1 % in the Al- and PMMA-equivalent thicknesses, respectively.
Figure 2: Equivalent PMMA and Al thicknesses, normalized to 10 mm sample thickness, for fresh and fixed samples of solid 
malignant breast tissue, normal adipose tissue, and normal glandular tissue, and compared to previously published data on cyst 
fluid and water (Fredenberg et al 2013). a) Overview of the Al-PMMA vectors for the average of fresh and fixed tissue. The 
angle  and magnitude  are illustrated on the cyst-fluid vector. Total variabilities ( , one standard deviation) are shown as 𝜃 𝑟 𝜎tot
error bars at the end of each vector. Dotted lines indicate  for atomic numbers . b) Overview of the distributions of 𝜃  𝑍 =  6 ― 8
fresh and fixed tissue (solid and dashed lines, respectively) for each tissue type. Individual measurement points are represented 
by the convex hulls. c-e) Close-ups of the measurement points on adipose, glandular, and malignant tissue. Error bars show the 
intra-image variability ( , one standard deviation) for each measurement point. Measurements on fresh tissue are indicated 𝜎intra I
by dots. The smallest  of the cyst-fluid samples is indicated with a red dotted line. The aspect ratio of the x and y axes 𝜃
approximates the relative attenuation lengths of Al and PMMA.
Figure 2 shows measurement results from this study, as well as for 50 samples of cyst fluid and 50 
samples of water from Fredenberg et al (2013), all expressed in terms of the equivalent Al and PMMA 
thicknesses, normalized to a sample thickness of 10 mm and a PMMA density of . Figure 2a) 1.19 g/cm3
shows an overview of the Al-PMMA vectors (average of fresh and fixed tissue) with the total variability (𝜎tot
) indicated as error bars at the end of each vector. The angle ( ) and magnitude ( ) are illustrated on the 𝜃 𝑟
cyst-fluid vector. The (effective) atomic number of the sample determines , and the angles for   𝜃  𝑍 =  6 ― 8
are indicated for illustration. Figure 2b) shows mean values and total variabilities ( ) for each sample type 𝜎tot
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as bold error bars, connected to the respective Al-PMMA vector, for fresh and fixed tissue. The individual 
measurement points are represented by their perimeters (convex hulls). Figure 2c-e) show close-ups of the 
measurements on adipose tissue, glandular, and malignant tissue. Individual measurement points are shown 
with error bars for the intra-image variability ( ). Measurements on fresh tissue are distinguished by 𝜎intra I
dots. The red dotted line in Figure 2e) indicates the smallest  of the cyst-fluid samples. In common with 𝜃
previous studies (Fredenberg et al 2016, Tomal et al 2010), we have bundled the data for malignant lesions 
of different type and grade. The aspect ratio of the x and y axes in Figure 2 (1:10) corresponds approximately 
to the relative attenuation lengths of Al and PMMA at mammography energies.
Table 2 lists all mean values and variability measures from the present study and from our previous 
study on solid tissue (Fredenberg et al 2016). Comparing present to previous data, there was a slight 
discrepancy in the mean values of fixed malignant tissue, but the difference was not significant (P > 0.05, 
two-sample t-test) and there is also no reason to expect a discrepancy. It therefore makes sense to attribute 
the difference to the large sample-to-sample variability, and the measures for a combined set of 83 samples 
in total are also listed in Table 2. In the following analysis we will, however, include only the current results, 
which have matching fresh tissue, but the larger data set on fixed tissue can be expected to have higher 
statistical power and may be useful outside this study. Further comparing the present data and our previous 
study, there was a relatively large and significant reduction in the total variability of PMMA thicknesses 
and  (42 % reduction, P < 0.01, two-sample F-test). The differences in total variability of Al thicknesses 𝑟
and  were, however, smaller and not significant (P > 0.3).𝜃
Table 2: Equivalent PMMA and Al thicknesses, normalized to 10 mm sample thickness, and the angle ( ) and magnitude ( ) of the 𝜃 𝑟
Al-PMMA vectors. Data from the following sample sets are listed: Fresh and fixed solid malignant, glandular, and adipose tissue 
from the present study (sample set: this), fixed malignant tissue from Fredenberg et al (2016) (sample set: 2016), and all fixed 
malignant tissue combined into a single set (sample set: comb.). The following information is given for each sample set and measure: 
The number of samples (n); fixation status (fix.); mean value of the measure; total (sample-to-sample) variability of the measure (𝜎tot
, one standard deviation) with the expected quantum-noise contribution ( ); intra-image (sub ROI) variability ( , one 𝜎quant S 𝜎intra I
standard deviation).
PMMA thickness [mm] Al thickness [mm]
Sample type set n fix. mean 𝝈𝐭𝐨𝐭 𝝈𝐪𝐮𝐚𝐧𝐭 𝐒 𝝈𝐢𝐧𝐭𝐫𝐚 𝐈 mean 𝝈𝐭𝐨𝐭 𝝈𝐪𝐮𝐚𝐧𝐭 𝐒 𝝈𝐢𝐧𝐭𝐫𝐚 𝐈
8.60 0.315this 27 x 8.64 0.13 0.02 0.08 0.284 0.027 0.002 0.008
2016 56 x 8.59 0.22 0.05 0.09 0.296 0.028 0.004 0.009malignant:
comb. 83 x 8.61 0.20 0.04 0.09 0.292 0.028 0.004 0.009
8.45 0.291glandular: this 7 x 8.56 0.17 0.02 0.16 0.262 0.021 0.002 0.020
8.33 - 0.089adipose: this 15 x 8.33 0.14 0.02 0.10 - 0.087 0.012 0.002 0.011
Magnitude ( ) [mm]𝒓 Angle ( ) [mrad]𝜽
Sample type set n fix. mean 𝝈𝐭𝐨𝐭 𝝈𝐪𝐮𝐚𝐧𝐭 𝐒 𝝈𝐢𝐧𝐭𝐫𝐚 𝐈 mean 𝝈𝐭𝐨𝐭 𝝈𝐪𝐮𝐚𝐧𝐭 𝐒 𝝈𝐢𝐧𝐭𝐫𝐚 𝐈
8.60 36.6this 27 x 8.64 0.13 0.02 0.08 32.9 3.2 0.3 1.0
2016 56 x 8.59 0.22 0.05 0.09 34.5 3.4 0.6 1.1malignant:
comb. 83 x 8.61 0.20 0.04 0.09 33.9 3.4 0.5 1.1
8.46 34.4glandular: this 7 x 8.56 0.17 0.02 0.16 30.6 2.6 0.2 2.5
8.33 - 10.7adipose: this 15 x 8.33 0.14 0.02 0.10 - 10.5 1.5 0.2 1.3
For malignant tissue, there were significant differences in attenuation between fresh and fixed tissue 
in terms of Al thickness and  (P < 0.01, two-sample t-test), but the differences in PMMA thickness and   𝜃 𝑟
were relatively smaller and not significant (P > 0.1). Compared to fixed lesions, the distribution of fresh 
lesions approached the previously published cyst-fluid distribution (the solid fresh-tissue vector in Figure 
2e) is closer to the red cyst-fluid vector than is the dashed fixed-tissue vector), and the two tissue types were 
not significantly different in terms of Al thickness (P > 0.1, two-sample t-test), but differed significantly in 
terms of PMMA thickness, , and  (P < 0.01). For normal glandular tissue, there were, as for malignant 𝜃 𝑟
tissue, significant average differences in attenuation between fresh and fixed tissue in terms of Al thickness 
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and  (P < 0.01, two-sample t-test), but not in terms of PMMA thickness or  (P > 0.1). There was a  𝜃 𝑟
consistent trend of all attenuation measures being slightly lower than for malignant tissue. If the 
measurements on fresh and fixed data for each sample are averaged (to increase power), this difference was 
close-to significant for all attenuation measures (P < 0.05, two-sample t-test). For normal adipose tissue, 
there was no significant difference between fresh and fixed tissue for any of the attenuation measures (P > 
0.5, two-sample t-test), which is also manifested by the almost complete overlap of the mean values for 
fresh and fixed tissue in Figure 2c).
For all tissue types, the differences in total variability between fresh and fixed tissue were not 
significant (P > 0.3, two-sample F-test). As discussed in Sec. 2.3, the variability measures listed in Table 2 
are therefore the averages of fresh and fixed tissue, and these average values were used in the following 
analysis of variability. For tumour tissue, the sample variability ( ) was significantly higher than the 𝜎intra I
expected quantum noise between ROIs (P < 0.01, two-sample t-test between  and ), in terms 𝜎intra I 𝜎quant I
of PMMA and  (53 % higher), and Al and  (78 % higher on average). Note that  is not listed in 𝑟 𝜃 𝜎quant I
Table 2 because the relationship to  stated in conjunction with Eq. (4) was found to hold, i.e. 𝜎quant S 𝜎quant I
. For glandular tissue, the PMMA and  sample variability was significantly higher than the = 2 × 𝜎quant S 𝑟
expected quantum noise (341 % higher, P < 0.01, two-sample t-test), and a close-to significant difference 
was found between the Al and  sample variability and the expected quantum noise (519 % higher on 𝜃
average, P < 0.05). For adipose tissue, the sample variability was significantly higher than the expected 
quantum noise (P < 0.01, two-sample t-test), in terms of PMMA and  (152 % higher), and Al and  (220 𝑟 𝜃
% higher on average). 
For all tissue types, the total variability ( ) was several times larger than the expected quantum 𝜎tot
noise (P < 0.01, chi-square variance test between  and ). There was no significant difference in 𝜎tot 𝜎quant S
total variability between malignant and glandular tissue (P > 0.1, two-sample F-test on the mean values). 
Malignant and glandular tissue exhibited significantly higher total variability than adipose tissue in terms 
of Al and  (on average 118 % higher for tumour tissue and 71 % higher for glandular tissue, P < 0.01). No 𝜃
significant difference was found in PMMA and  total variability between adipose tissue and the other tissue 𝑟
types (P > 0.10).
For reference and comparison to other studies, the linear attenuation coefficients of fresh and fixed 
malignant, adipose, and glandular breast tissue, calculated from the measured PMMA- and Al-equivalent 
thicknesses at a range of x-ray energies relevant to mammography, are shown in Table 3. 
Table 3: Linear attenuation coefficients of malignant and normal glandular and adipose breast tissue calculated from the measured 
PMMA- and Al-equivalent thicknesses. The number of samples (n) and fixation status (fix.) are listed for each sample set. The total 
variability ( , one standard deviation) is given in parenthesis.𝜎tot
linear attenuation [ ]cm ―𝟏
Sample type n fix. 15 keV 20 keV 25 keV 30 keV 35 keV 40 keV
1.80 (0.054) 0.877 (0.023) 0.551 (0.012) 0.406 (0.008) 0.332 (0.006) 0.289 (0.004)malignant: 27 x 1.74 (0.053) 0.851 (0.023) 0.538 (0.012) 0.398 (0.007) 0.326 (0.005) 0.285 (0.004)
1.73 (0.045) 0.845 (0.020) 0.532 (0.010) 0.394 (0.007) 0.322 (0.005) 0.281 (0.004)glandular: 7 x 1.69 (0.022) 0.825 (0.009) 0.523 (0.004) 0.388 (0.003) 0.319 (0.003) 0.280 (0.003)
0.902 (0.027) 0.484 (0.012) 0.338 (0.007) 0.273 (0.005) 0.239 (0.004) 0.219 (0.004)adipose: 15 x 0.906 (0.037) 0.486 (0.017) 0.339 (0.010) 0.274 (0.007) 0.240 (0.006) 0.220 (0.005)
4. Discussion
4.1. Measurement variability
As we have noted previously (Fredenberg et al 2016), the total variability ( ) of tumour samples is 𝜎tot
substantially larger than what would be expected from measurement errors (i.e., thickness errors of the 
measurement setup – ,  – and quantum noise – ). Referring to Eq. (4), a large part of  for 𝜎th S 𝜎th I 𝜎quant S 𝜎tot
tumour tissue can therefore be explained by natural variation (  and ). In particular the Al 𝜎inter S 𝜎intra S
variability is more strongly associated with natural variation (random measurement errors constitute 
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approximately 10 % of ), whereas the PMMA variability contains a larger component of measurement 𝜎tot
errors (approximately 30 %). This difference can be understood by modelling the natural variation of tumour 
tissue as a blending with other tissue types (in particular glandular tissue); considering the span of tissue 
attenuation in the present study we see that the spread is mainly in the Al direction. As a consequence of the 
steep , the behaviour of  variability follows approximately that of PMMA and the  variability follows 𝜃 𝑟 𝜃
Al.
For glandular tissue, the total variability was not significantly different from that of tumour tissue and 
the contribution by random measurement errors was approximately the same in Al thicknesses (10%). For 
adipose tissue on the other hand, the total variability in Al thicknesses was significantly lower than for any 
of the other tissue types. Random measurement errors constitute approximately 15% of the variability in Al, 
which is higher than for glandular and tumour tissue. As discussed above, Al thicknesses have a stronger 
association to natural variation and these results therefore indicate that adipose tissue has the lowest natural 
variation of the investigated tissues. The high homogeneity of the adipose tissue samples was also 
corroborated by visual inspection; the adipose samples appeared more homogeneous on the x-ray images.
Compared to our previous study on solid malignant breast tissue,  was significantly and 𝜎tot
substantially lower in terms of PMMA thickness and , but not in terms of Al thickness or . Following the 𝑟 𝜃
discussion above, the reduction in total variability in PMMA and  implies a reduction in measurement 𝑟
errors, which makes sense because there is no reason to expect a reduction in natural tissue variation. The 
average sample thicknesses were approximately the same in both studies (6.8 mm vs. 6.4 mm), but because 
of larger ROI sizes in the present study (89 mm2 vs. 54 mm2), the quantum noise was lower, which may 
account for part of the reduction in . Further, even though the measurement setups were identical in the 𝜎tot
two studies, the manual thickness measurement of the sample might be associated with a learning curve so 
that the precision has improved over time (lower ). Another learning curve might be coupled to the 𝜎th S
tissue handling, leading to less unevenness of the sample (lower ).𝜎th I
Another difference compared to our previous results is that, in the present study,  for tumour 𝜎intra I
tissue was significantly larger than , whereas previously no significant difference was found. The 𝜎quant I
reason for this discrepancy may be the larger ROI sizes, which together with averaging of the four readings 
reduces the quantum noise so that intra-image variations (  and ) become more visible. Further, as 𝜎intra S 𝜎th I
noted in Sec. 2.3, it is likely that  and  grow with distance between the sub ROIs and will therefore 𝜎intra S 𝜎th I
be higher for the larger ROI sizes in the present study. For glandular and adipose tissue, the ROI sizes were 
larger than for tumour tissue, which certainly resulted in lower quantum noise, but as an effect of the 
spreading of the four sub ROIs, random fluctuations within each sample ( ) were substantially higher 𝜎intra I
than for tumour tissue and constituted a substantially larger portion of .𝜎tot
4.2. Discrimination between tissue types
Roughly speaking, x-ray attenuation is determined by the effective atomic number, density (specific 
weight), and thickness of the attenuating material. Spectral imaging enables differentiation between atomic 
number and density by measuring the energy dependence of the attenuation (Fredenberg 2018). It may 
therefore be possible to discriminate between cyst fluid, glandular tissue, and solid malignant tissue despite 
the very small differences in linear attenuation (approximately 3% average difference in the 15-40 keV 
interval according to Table 3 and Fredenberg et al (2013), Table 4) because the energy dependencies are 
not the same. In terms of the Al-PMMA vector, spectral imaging enables measurement of the angle ( ), 𝜃
which is related to the effective atomic number and independent of the sample thickness, whereas the 
magnitude ( ) is directly proportional to both the density and the thickness of the sample and therefore 𝑟
cannot be used for material discrimination unless the thickness is known. In clinical applications, the 
thickness may be available from 3D information or from assumptions of slow thickness variations, but it 
may also be an unknown variable, in which case  can be used for discrimination.𝜃
Fredenberg et al (2016) concluded that the attenuation of cyst fluid and fixed tumour specimens 
differed significantly in terms of  and , but one concern raised was that formalin-fixed tissue was used as 𝜃 𝑟
opposed to fresh tissue, which is a potential bias when making direct interpretation of the results to a clinical 
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situation. The present measurements on fresh tumour tissue showed a smaller, although still significant, 
difference compared to cyst fluid in terms of  and . Hence, discrimination of these two tissue types in 𝜃 𝑟
clinical practice may be more challenging than previously believed, but is still possible as also evidenced 
by a clinical pilot study conducted by Erhard et al (2016). Despite the large spread, no solid samples fall 
within the shaded region of the cyst distribution (Figure 2), but 15 malignant samples (56% of the total 
number) overlap with the cyst distribution in terms of  (Figure 2, area below the dotted line), and these 𝜃
samples would therefore be challenging to distinguish from cyst fluid.
We found a close-to significant difference between normal glandular tissue and malignant tissue in 
terms of all attenuation measures. Both  and  were slightly higher for malignant tissue, which implies 𝜃 𝑟
higher effective atomic number and higher density than glandular tissue. This finding involved averaging 
over fresh and fixed tissue to increase statistical power. The result should therefore be treated with caution, 
but it is reasonable to expect a significant difference between the two tissue types with a larger set of 
glandular tissue samples. The difficulty to discriminate between the attenuation of glandular and malignant 
tissue is further underlined by mixed results in the literature; two previous studies have found significant 
differences between malignant and glandular tissue at lower energies (Johns and Yaffe 1987, Tomal et al 
2010), whereas at least one other study was not able to show a significant difference (Chen et al 2010).
4.3. Comparison to published data
Figure 3 shows a comparison in terms of the equivalent Al and PMMA thicknesses between the data 
presented in this study and most of the attenuation data on breast tissue available in the literature. The mean 
values and total variabilities of the present study are represented by error bars, overlaid on the convex hulls 
of all measured data. Published studies are represented by filled (fresh) and open (fixed) markers, and the 
average of all studies, as well as the variation between mean values (one standard deviation), are shown as 
error bars. Mean values and variabilities are also listed in Table 4. In some cases, uncertainty measures are 
available from individual published studies, but these are not shown as variabilities in Figure 3 or Table 4 
because no consistent way of converting linear attenuation uncertainty to Al and PMMA space could be 
found.
The studies included in Figure 3, Table 4, and the following analysis are: Hammerstein et al (1979), 
elemental composition of fresh tissue, 8 samples of adipose tissue, 5 samples of glandular tissue; Johns and 
Yaffe (1987), linear attenuation of fresh tissue in the energy range 18-110 keV, 7 samples of adipose tissue, 
8 samples of fibrous tissue, 6 samples of infiltrating ductal carcinoma; Chen et al (2010), linear attenuation 
of fixed tissue in the energy range 15-26.5 keV (but all samples were not imaged at all energies), ≤13 
samples of fibrous tissue, ≤17 samples of adipose tissue, ≤14 samples of cancerous tissue, mainly ductal 
carcinoma; Tomal et al (2010), linear attenuation coefficient of fixed tissue in the energy range 8-30 keV, 
4 samples of glandular tissue, 28 samples of adipose tissue, 18 invasive ductal carcinomas, 6 fibroadenomas. 
Data from Woodard and White (1986), Carroll et al (1994), and Poletti et al (2002) were not included 
because the samples could not be unambiguously categorized as fresh or fixed.
For calculating the average of fixed tumour attenuation, we have treated our previous study 
(Fredenberg et al 2016) and the present one as separate studies, although the systematic errors are likely 
similar. The resulting higher weighting of our results can be motivated by the considerably larger set of 
samples (83 samples in the two studies) compared to other studies (∼32 samples in total), which likely 
yields lower random errors. Equivalent Al and PMMA thicknesses for published data were found by fitting 
to linear attenuation coefficients according to Eq. (3) in Fredenberg et al (2016), under the conditions of 10 
mm tissue thickness and  PMMA density. The validity of this fit is explained in Fredenberg et 1.19 g/cm3
al (2016). For attenuation data based on elemental composition, the linear attenuation was first calculated 
by the mixture rule and elemental attenuation from Berger et al (2009).
The relatively large spread in the available data on tissue attenuation may be caused by 1) large natural 
spread between samples, 2) random measurement errors, and 3) different experimental conditions in the 
different studies that cause systematic differences and errors (Fredenberg et al 2016). Assuming that random 
fluctuations (uncertainties 1 and 2) are approximately the same in all studies and that the systematic errors 
(uncertainty 3) are random between studies, adding more studies to the literature will help reduce the error 
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of the mean, and it is fair to assume that the mean values (error bars in Figure 3 and values in Table 4) 
represent better estimates of the expectation values than do the individual studies.
Chen et al (2010) measured the linear attenuation coefficients before and after formalin fixation for 
six of their samples, and the fitted Al- and PMMA-equivalent thicknesses are shown in Figure 3 and Table 
4. The mean values for the subset of fixed tissue (cyan filled circles) do not in all cases agree with those of 
the full study (black or green filled circles), a discrepancy that may be caused by the use of a smaller number 
of samples and the narrower energy range (17-23 keV) compared to the full set of data. Data for the six 
fresh samples were therefore not included when calculating the mean of all studies. The differences between 
fixed tissue (Figure 3, cyan open circle) and fresh tissue (cyan filled circle) within the subset are, however, 
likely less prone to systematic errors as these can be expected to cancel when taking the difference. On the 
other hand, the differences are subject to random errors from both measurements, with the exception of 
sample-to-sample tissue variation ( ) as the same samples were used for measurements on both fresh 𝜎inter S
and fixed tissue.
Figure 3: The data presented in this study (thin error bars and convex hulls) compared to Al- and PMMA-equivalent thicknesses 
calculated from published data on breast tissue, fresh (Hammerstein et al 1979, Johns and Yaffe 1987) and formalin fixed (Chen 
et al 2010, Tomal et al 2010, Fredenberg et al 2016). The averages and variabilities (one standard deviation) of all studies are 
represented by bold error bars. Data from Chen et al (2010) on fresh vs. fixed tissue are shown as cyan markers. The aspect ratio 
of the x and y axes approximates the relative attenuation lengths of Al and PMMA. 
Similarly, the differences between fresh and fixed tissue measured in this study can be expected to 
contain a low level of systematic errors and, in addition, a lower level of random errors than the measurement 
by Chen et al (2010) because of the larger number of samples. The differences are listed in Table 4 along 
with the variability (the standard deviation over individual samples). The calculated differences between 
separate studies on fresh and fixed tissue are also listed in Table 4. Even though this calculation includes 
the largest number of samples, systematic errors and sample to sample variation can be expected to influence 
the results. In fact, the variability of the difference (propagated from the variability between studies) is in 
all cases larger than the variability for the present study.
For malignant tissue and glandular tissue, our results agree qualitatively with Chen et al (2010) as 
well as with the average of all studies, i.e., the fixation process yields higher equivalent PMMA thickness 
and lower equivalent Al thickness. For adipose tissue, Chen et al (2010) did not, in agreement with our 
study, find a significant difference between fresh and fixed tissue, which indicates low uptake of formalin 
in adipose tissue and an otherwise negligible effect of fixation. The difference between different publications 
on fresh and fixed adipose tissue is relatively large, but given the substantial variability in the estimation, 
the deviation is not significant.
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5. Conclusions
The present study marks the next step in our efforts to characterize breast tissue attenuation. The series of 
studies now include cyst fluid and tumour tissue, as well as normal adipose and glandular tissue, all 
measured with close-to identical methods and in an environment relevant for screening mammography.
Solid samples exhibit large sample-to-sample variation compared to liquid samples and compared to 
what would be expected from measurement errors. We expect a major part of the variability, in particular 
for Al-equivalent thicknesses and , to be caused by natural spread between samples. The natural variation 𝜃
of tumour tissue and glandular tissue is similar, whereas that of adipose tissue appears to be lower.
Fixation does not affect the attenuation of adipose tissue significantly, but yields higher equivalent 
PMMA thickness and lower equivalent Al thickness for malignant tissue and glandular tissue. 
Consequently, fresh tumour tissue showed a smaller, although still significant, difference compared to cyst 
fluid than has previously been measured for fixed tissue. Hence, discrimination of these two tissue types 
with spectral mammography may be more challenging than previously believed, but is still possible, as 
corroborated by a clinical pilot study conducted by Erhard et al (2016). The difference between normal 
glandular tissue and malignant tissue would likely be significant with a larger set of glandular tissue samples.
The present study contributes to lower the overall uncertainty in the literature by 1) a relatively large 
sample set, which reduces random errors and the effect of natural spread, 2) adding another measurement 
method, which helps reduce systematic uncertainty, and 3) clarifying the difference between fresh and 
formalin-fixed tissue, one of the major contributors to systematic discrepancies.
Table 4: Comparison of the equivalent PMMA and Al thicknesses, stratified on fresh and fixed tissue (fix.) and normalized to 10 
mm tissue thickness, for the average of all published studies on each tissue type (including the present study), as measured by Chen 
et al (2010), and as measured in the present study. Mean values as well as the difference between mean values are given. For each 
set, the number of samples (Chen et al, this study), or the number of studies (all studies), are listed as n. Variability measures are 
given in parenthesis as the total variability (this study) or the variation between mean values (all studies). No variabilities are given 
for Chen et al (2010) because the published linear attenuation uncertainty could not be unambiguously converted to Al and PMMA.
PMMA thickness [mm] Al thickness [mm]
Sample type Set n fix. mean difference mean difference
2 8.45 (0.21) 0.308 (0.010)all studies 3 x 8.73 (0.34) - 0.28 (0.40) 0.270 (0.038) 0.037 (0.039)
8.31 0.297Chen et al 6 x 8.45 - 0.14 0.252 0.046
8.60 0.315
malignant:
this study 27 x 8.64 (0.13) - 0.04 (0.13) 0.284 (0.027) 0.031 (0.026)
3 8.36 (0.09) 0.259 (0.031)all studies 3 x 8.79 (0.24) - 0.42 (0.26) 0.226 (0.042) 0.033 (0.052)
8.26 0.295Chen et al 6 x 8.65 - 0.20 0.241 0.043
8.45 0.291
glandular:
this study 7 x 8.56 (0.17) - 0.10 (0.15) 0.262 (0.021) 0.029 (0.010)
3 8.25 (0.08) - 0.084 (0.034)all studies 3 x 8.45 (0.19) - 0.21 (0.21) - 0.107 (0.046) 0.023 (0.057)
7.96 - 0.121Chen et al 6 x 7.99 - 0.03 - 0.116 - 0.005
8.33 - 0.089
adipose:
this study 15 x 8.33 (0.14) 0.00 (0.15) - 0.087 (0.012) 0.001 (0.011)
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